Baycol
Baycol, also known as Cerivastatin Sodium, was approved for use in 1997. It is a popular cholesterol-lowering drug and is prescribed to control the excess cholesterol in the bloodstream that leads to hardening of the arteries and heart disease. Approximately 700,000 Americans were prescribed with the drug. Baycol was intended to lower both total cholesterol and LDL ("bad") cholesterol, while raising the HDL ("good") cholesterol that clears the arteries. Patients taking Baycol, however, have experienced severe rhabdomyolysis resulting in kidney failure and death. On August 8, 2001, Bayer, the manufacturer of Baycol, voluntarily withdrew the drug from the market due to reports of fatal rhabdomyolysis.
The FDA has received 31 reports of deaths due to severe Rhabdomyolysis associated with Baycol. Bayer, however, is attributing 52 deaths to Baycol. To date, many lawsuits have already been filed and several are seeking class action status.
If you or a loved one has suffered an injury as a result of taking any drug or supplement, call Littman & Babiarz, Attorneys at Law now at 607-277-7527 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.
<< back
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
